Diabetes 50:1627-1635, 2001
© 2001 by the American Diabetes Association, Inc.
Glucose Effects on Skin Keratinocytes
Implications for Diabetes Skin Complications
Natalia Spravchikov1,
Galina Sizyakov1,
Marina Gartsbein2,
Domenico Accili3,
Tamar Tennenbaum2, and
Efrat Wertheimer1
1 Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv
2 Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
3 Columbia University/Berrie Research Pavilion, New York, New York
Altered skin wound healing is a common cause of morbidity and mortality among diabetic patients. However, the molecular mechanisms whereby diabetes alters skin physiology have not been elucidated. In this study, we investigated the relative roles of hyperglycemia, insulin, and IGF-I, all of which are abnormal in diabetes, in primary murine skin keratinocytes. These cells proliferate and differentiate in vitro in a manner similar to skin in vivo. It was found that in the presence of high glucose (20 mmol/l), the glucose transport rate of primary proliferating or differentiating keratinocytes was downregulated, whereas at 2 mmol/l glucose, the transport rate was increased. These changes were associated with changes in the GLUT1 expression and with changes in the affinity constant (Km) of the transport. Exposure to high glucose was associated with changes in cellular morphology, as well as with decreased proliferation and enhancement of Ca2+-induced differentiation of keratinocytes. Furthermore, in the presence of high glucose, ligand-induced IGF-I receptor but not insulin receptor (IR) autophosphorylation was decreased. Consequently, in high glucose, the effects of IGF-I on glucose uptake and keratinocyte proliferation were inhibited. Interestingly, lack of IR expression in IR-null keratinocytes abolished insulin-induced glucose uptake and partially decreased insulin- and IGF-Iinduced proliferation, demonstrating the direct involvement of the IR in these processes. Our results demonstrate that hyperglycemia and impaired insulin signaling might be directly involved in the development of chronic complications of diabetes by impairing glucose utilization of skin keratinocytes as well as skin proliferation and differentiation.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Goren, E. Muller, J. Pfeilschifter, and S. Frank
Severely Impaired Insulin Signaling in Chronic Wounds of Diabetic ob/ob Mice: A Potential Role of Tumor Necrosis Factor-{alpha}
Am. J. Pathol.,
March 1, 2006;
168(3):
765 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Dinh and A. Veves
A Review of the Mechanisms Implicated in the Pathogenesis of the Diabetic Foot
International Journal of Lower Extremity Wounds,
September 1, 2005;
4(3):
154 - 159.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sadagurski, G. Weingarten, C. J. Rhodes, M. F. White, and E. Wertheimer
Insulin Receptor Substrate 2 Plays Diverse Cell-specific Roles in the Regulation of Glucose Transport
J. Biol. Chem.,
April 15, 2005;
280(15):
14536 - 14544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lobmann, G. Schultz, and H. Lehnert
Proteases and the Diabetic Foot Syndrome: Mechanisms and Therapeutic Implications
Diabetes Care,
February 1, 2005;
28(2):
461 - 471.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight
Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems
Endocr. Rev.,
December 1, 2003;
24(6):
737 - 764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Zagon, J. B. Jenkins, J. W. Sassani, J. D. Wylie, T. B. Ruth, J. L. Fry, C. M. Lang, and P. J. McLaughlin
Naltrexone, an Opioid Antagonist, Facilitates Reepithelialization of the Cornea in Diabetic Rat
Diabetes,
October 1, 2002;
51(10):
3055 - 3062.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|